These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 21820782)

  • 21. Public participation in regional health policy: a theoretical framework.
    Thurston WE; MacKean G; Vollman A; Casebeer A; Weber M; Maloff B; Bader J
    Health Policy; 2005 Sep; 73(3):237-52. PubMed ID: 16039343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Swiss Technology Assessment project on xenotransplantation.
    Bellucci S; Bondolfi A; Hüsing B; Rüegsegger A
    Ann N Y Acad Sci; 1998 Dec; 862():155-65. PubMed ID: 9928219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Public participation in the process of local public health policy, using policy network analysis.
    Park Y; Kim CY; You MS; Lee KS; Park E
    J Prev Med Public Health; 2014 Nov; 47(6):298-308. PubMed ID: 25475197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hospital personnel faced with organ xenotransplantation: an attitudinal survey in a hospital with a pre-clinical liver xenotransplantation program.
    Ríos A; Conesa C; Ramírez P; Galindo PJ; Rodríguez MM; Martínez L; Montoya MJ; Rodríguez JM; Parrilla P
    Xenotransplantation; 2006 Sep; 13(5):447-54. PubMed ID: 16925669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intelligent policy making? Key actors' perspectives on the development and implementation of an early years' initiative in Scotland's public health arena.
    Deas L; Mattu L; Gnich W
    Soc Sci Med; 2013 Nov; 96():1-8. PubMed ID: 24034945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmaceutical companies and Italian Regional Governments: managing relationships in an increasing institutional complexity.
    Compagni A; Cavalli L; Jommi C
    Health Policy; 2008 Sep; 87(3):333-41. PubMed ID: 18384907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of state and non-state actors in the policy process: the contribution of policy networks to the scale-up of antiretroviral therapy in Thailand.
    Tantivess S; Walt G
    Health Policy Plan; 2008 Sep; 23(5):328-38. PubMed ID: 18658197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Citizen participation in health decision-making: past experience and future prospects.
    Church J; Saunders D; Wanke M; Pong R; Spooner C; Dorgan M
    J Public Health Policy; 2002; 23(1):12-32. PubMed ID: 12013713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impacts of an HIA on inter-agency and inter-sectoral partnerships and community participation: lessons from a local level HIA in the Republic of Ireland.
    Pursell L; Kearns N
    Health Promot Int; 2013 Dec; 28(4):522-32. PubMed ID: 22821083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deliberative Public Consultation via Deliberative Polling: Criteria and Methods.
    Fishkin JS
    Hastings Cent Rep; 2021 Nov; 51 Suppl 2():S19-S24. PubMed ID: 34905249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. France's citizen consultation on vaccination and the challenges of participatory democracy in health.
    Ward JK; Cafiero F; Fretigny R; Colgrove J; Seror V
    Soc Sci Med; 2019 Jan; 220():73-80. PubMed ID: 30408684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Managing partnerships and impact on decision-making: the example of health technology assessment in genetics.
    Blancquaert I
    Community Genet; 2006; 9(1):27-33. PubMed ID: 16490956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Examining the role of context in the implementation of a deliberative public participation experiment: results from a Canadian comparative study.
    Abelson J; Forest PG; Eyles J; Casebeer A; Martin E; Mackean G
    Soc Sci Med; 2007 May; 64(10):2115-28. PubMed ID: 17368680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Moving cautiously: Public involvement and the health technology assessment community.
    Gauvin FP; Abelson J; Giacomini M; Eyles J; Lavis JN
    Int J Technol Assess Health Care; 2011 Jan; 27(1):43-9. PubMed ID: 21262071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Learning to practice in Canada: the hidden curriculum of international medical graduates.
    Lockyer J; Fidler H; de Gara C; Keefe J
    J Contin Educ Health Prof; 2010; 30(1):37-43. PubMed ID: 20222032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathways to translating experiential knowledge into mental health policy.
    Restall G; Cooper JE; Kaufert JM
    Psychiatr Rehabil J; 2011; 35(1):29-36. PubMed ID: 21768075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improving drug policy: The potential of broader democratic participation.
    Ritter A; Lancaster K; Diprose R
    Int J Drug Policy; 2018 May; 55():1-7. PubMed ID: 29428297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A consumer involvement model for health technology assessment in Canada.
    Pivik J; Rode E; Ward C
    Health Policy; 2004 Aug; 69(2):253-68. PubMed ID: 15212871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The xenotransplantation question: public consultation is an important part of the answer.
    Ivinson AJ; Bach FH
    CMAJ; 2002 Jul; 167(1):42-3. PubMed ID: 12137078
    [No Abstract]   [Full Text] [Related]  

  • 40. Code of ethics: CMA policy summary.
    Canadian Medical Association
    CMAJ; 1987 Oct; 137(8):760A-D. PubMed ID: 11658965
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.